Dr. Harsfalvi Jolan
Dr. Harsfalvi Jolan
E-mail megerősítve itt: med.semmelweis-univ.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Antithrombotic effect of platelet glycoprotein Ib–blocking monoclonal antibody Fab fragments in nonhuman primates
N Cauwenberghs, M Meiring, S Vauterin, V Van Wyk, S Lamprecht, ...
Arteriosclerosis, thrombosis, and vascular biology 20 (5), 1347-1353, 2000
1452000
Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions
J Harsfalvi, JM Stassen, MF Hoylaerts, E Van Houtte, RT Sawyer, ...
1121995
Factor XIII, clot structure, thrombosis
Z Bagoly, Z Koncz, J Hársfalvi, L Muszbek
Thrombosis research 129 (3), 382-387, 2012
1032012
Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections
M Papp, Z Vitalis, I Altorjay, I Tornai, M Udvardy, J Harsfalvi, A Vida, ...
Liver International 32 (4), 603-611, 2012
982012
Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of …
N Cauwenberghs, K Vanhoorelbeke, S Vauterin, DF Westra, G Romo, ...
Blood, The Journal of the American Society of Hematology 98 (3), 652-660, 2001
972001
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype …
M Papp, I Altorjay, GL Norman, Z Shums, K Palatka, Z Vitalis, I Foldi, ...
Inflammatory bowel diseases 13 (8), 984-992, 2007
862007
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia
A Molvarec, J Rigó Jr, T Bõze, Z Derzsy, L Cervenak, V Makó, T Gombos, ...
Thrombosis and haemostasis 101 (02), 305-311, 2009
702009
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease
PL Lakatos, LS Kiss, K Palatka, I Altorjay, P Antal-Szalmas, E Palyu, ...
Inflammatory bowel diseases 17 (3), 767-777, 2011
652011
Phage display selection of efficient glutamine‐donor substrate peptides for transglutaminase 2
Z Keresztessy, É Csősz, J Hársfalvi, K Csomós, J Gray, RN Lightowlers, ...
Protein science 15 (11), 2466-2480, 2006
592006
Shear-dependent morphology of von Willebrand factor bound to immobilized collagen
L Novák, H Deckmyn, S Damjanovich, J Hársfalvi
Blood, The Journal of the American Society of Hematology 99 (6), 2070-2076, 2002
542002
Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII: C inhibitor.
G Pfliegler, Z Boda, J Harsfalvi, M Flora-Nagy, B Sari, K Pecze, K Rak
Postgraduate Medical Journal 65 (764), 400-402, 1989
471989
4‐Thio‐deoxyuridylate‐modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix
S Mendelboum Raviv, A Horvath, J Aradi, Z Bagoly, F Fazakas, Z Batta, ...
Journal of Thrombosis and Haemostasis 6 (10), 1764-1771, 2008
462008
Factor XIII mediates adhesion of platelets to endothelial cells through αvβ3 and glycoprotein IIb/IIIa integrins
R Dardik, B Shenkman, I Tamarin, R Eskaraev, J Harsfalvi, D Varon, ...
Thrombosis research 105 (4), 317-323, 2002
422002
Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations
M Papp, I Foldi, E Nemes, M Udvardy, J Harsfalvi, I Altorjay, I Mate, ...
Clinical chemistry 54 (4), 697-704, 2008
402008
Enhanced release of IL-6 and IL-8 into tears in various anterior segment eye diseases
M Fodor, A Facskó, É Rajnavölgyi, J Hársfalvi, E Bessenyei, L Kardos, ...
Ophthalmic research 38 (4), 182-188, 2006
392006
Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure
T Gombos, V Makó, L Cervenak, J Papassotiriou, J Kunde, J Hársfalvi, ...
Thrombosis and haemostasis 102 (09), 573-580, 2009
372009
The most severe forms of Perthes’ disease associated with the homozygous Factor V Leiden mutation
K Szepesi, E Posan, J Harsfalvi, E Ajzner, G Szücs, L Gaspar, ...
The Journal of Bone and Joint Surgery. British volume 86 (3), 426-429, 2004
352004
Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head
E Pósán, K Szepesi, L Gáspár, Z Csernátony, J Hársfalvi, É Ajzner, A Tóth, ...
Blood coagulation & fibrinolysis 14 (3), 243-248, 2003
352003
Haptoglobin polymorphisms are associated with Crohn’s disease, disease behavior, and extraintestinal manifestations in Hungarian patients
M Papp, PL Lakatos, K Palatka, I Foldi, M Udvardy, J Harsfalvi, I Tornai, ...
Digestive diseases and sciences 52 (5), 1279-1284, 2007
322007
The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI
A Bonnefoy, J Harsfalvi, G Pfliegler, F Fauvel-Lafève, C Legrand
Thrombosis and haemostasis 85 (03), 552-559, 2001
322001
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20